Mylan
Top View
- 2015 Valeant Pharmaceuticals Annual Report
- Mylan Sign-On Letter
- Mylan Wins Its Amlodipine Case with Pfizer
- 180-Day Exclusivity Under the Hatch-Waxman Amendments to The
- Johnson & Johnson
- Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’S Need for Medicine
- FORM 10-Q Johnson & Johnson
- Johnson & Johnson 2016 Annual Report
- Phrma Brief on Venue
- Case 1:15-Cv-00760-SLR Document 33 Filed 01/26/16 Page 1 of 18 Pageid #: 641
- Filed by Mylan NV Pursuant to Rule 425
- Mylan Provides Update on Meridian Medical Technologies', a Pfizer Company, Expanded Voluntary Worldwide Recall of Epipen® Auto-Injector
- O:\CIVIL\Wyeth V. Mylan\Markman Hearing\Markman Order 5.Wpd
- COUNTY of LUBBOCK Plaintiff
- Mylan Launches Gilead Sciences' Sovaldi® Tablets in India
- The End Is Nigh for Mylan, but How Different Will the New Company
- Case 2:20-Cv-02065-DDC-TJJ Document 49 Filed 06/18/20 Page 1 of 15
- 1- in the United States District Court for the Northern